| Literature DB >> 32504295 |
Babak Arjmand1,2, Parisa Goodarzi3, Sepideh Alavi-Moghadam4, Moloud Payab5, Hamid Reza Aghayan6, Fereshteh Mohamadi-Jahani3, Akram Tayanloo-Beik6, Neda Mehrdad7, Bagher Larijani8.
Abstract
Schwann cells as glial cells in the peripheral nervous system can participate in neurons protection and forming myelin. Additionally, they are important for nerve pulse conduction supporting along axons. On the other hand, it was demonstrated that they are promising cells for the treatment of demyelinating disorders and also central nervous system damages. Herein, for therapeutic application, Schwann cells should be manufactured based on good manufacturing practice standards to achieve safe and effective clinical products. In this respect, the current chapter tries to introduce a standard protocol for manufacturing of human GMP-compliant Schwann cells for clinical application.Entities:
Keywords: Clinical application; GMP; Peripheral nervous system; Quality assurance; Schwann cells
Year: 2021 PMID: 32504295 DOI: 10.1007/7651_2020_283
Source DB: PubMed Journal: Methods Mol Biol ISSN: 1064-3745